Report Overview

The global Palliative Care in Cancer drugs market size is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

While providing the care service, along with considering the physical aspect, spiritual & psychological elements are also incorporated in the care plan, which helps in delivering holistic care services. While the help of this care service, the quality of life of the patients suffering from terminally ill conditions are enhanced. Moreover, to ascertain achieving the desired impact from the care service, it is also provided to their family members, which turns out to be beneficial in coping up with the stress and symptom of these diseases. To help the family members cope up in cases of bereavement, they are provided with bereavement counselling. Thus, factors like increasing incidence rate of life-threatening conditions like cancer, the rising awareness about the significance of this care service among care users are propelling the growth of the market



Market Drivers

Increase in chronic life-threatening diseases, reimbursement from Medicaid and Medicare, surge in the aging population, favorable initiative taken by the government and non- profit organization and rise in government funding in healthcare system are the factors that drive the growth of the market. Palliative care centers are recognized as a medical subspecialty by the American board of medical specialties and in Canada, England, Australia, New Zealand and Ireland. European countries are also in the process of developing a certification of palliative care. Palliative centers are also being developed in nations such as India, Indonesia, Brazil, and China. The palliative services market is being established in these markets and is expected to be in great demand with rise in awareness.